Full Issue

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Jan/Feb 2025 - Volume 29, Number 1

Purchase the entire back issue in electronic PDF or print format.

(Select Format)

Purchase or view individual articles by selecting the article in the table below...

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Individual Articles - Jan/Feb 2025 - Volume 29, Number 1
Prescription - Continuation, Compounding and Collaboration Kupiec Thomas C	Jan/Feb 2025 Pg. 4
Navigating the Direct Importation of Active Pharmaceutical Ingredients: Compliance Considerations for Compounding Pharmacies Wynn Tom, Thompson Chad	Jan/Feb 2025 Pg. 6-13
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Kumaravelrajan Rajagopal, Rockiyasamy Kishore metha, Venkatesan Suba, Thiraviam Purushoth Prabhu	Jan/Feb 2025 Pg. 14-21
Best Practices When Compounding FDA-Approved Drugs Listed in Storage Alliance for Pharmacy Compounding	Jan/Feb 2025 Pg. 22-27
Best Practices for Marketing Compounded Medications Alliance for Pharmacy Compounding	Jan/Feb 2025 Pg. 28-32
Compounded GLP-1 Drugs and Patient Adverse Events Alliance for Pharmacy Compounding	Jan/Feb 2025 Pg. 33-36
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations	Jan/Feb 2025 Pg. 38-39
Calculations - Salicylic Acid Ointments - Percent Strength of a Semisolid Dosage Form, Alligation Alternate Method of Calculation, Temperature Conversion Stockton Shelly J	Jan/Feb 2025 Pg. 40
Allopurinol 20-mg/mL Oral Suspension	Jan/Feb 2025 Pg. 42
Chloral Hydrate 25-mg/mL Oral Suspension	Jan/Feb 2025 Pg. 43-44
Ketoprofen 10% in Pluronic Lecithin Organogel	Jan/Feb 2025 Pg. 45
Lansoprazole 3-mg/mL Oral Suspension	Jan/Feb 2025 Pg. 46
Levothyroxine Sodium 40-ug/mL Oral Liquid	Jan/Feb 2025 Pg. 47
Nifedipine 0.5% Rectal Ointment	Jan/Feb 2025 Pg. 48
Rifaximin 20-mg/mL Oral Suspension	Jan/Feb 2025 Pg. 49
Sertraline Hydrochloride 10-mg/mL Oral Suspension	Jan/Feb 2025 Pg. 50
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution	Jan/Feb 2025 Pg. 51
Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis Guth Michael AS	Jan/Feb 2025 Pg. 52-63
Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions Kegele Carolina Schettino, Marianni Bruna, Polonini Hudson	Jan/Feb 2025 Pg. 64-76
Biopharmaceutical Performance of DiluCap: A Line of Functional Excipients Enhancing Dissolution Profiles of Minoxidil, Finasteride, Melatonin, and Naltrexone Kegele Carolina Schettino, Ferreira Anderson de Oliveira, Koulouridas Savvas, Polonini Hudson	Jan/Feb 2025 Pg. 77-84
Return to Top

	PDF — $95